Neurodegenerative Disease Therapeutics Industry Growth Forecasts - A USD 28.15 Billion By 2022
Neurodegenerative Disease Therapeutics Industry Data Book Covers Parkinson’s Disease Treatment and Alzheimer's Therapeutics Markets. The global neurodegenerative disease markets combine to account for USD 8.33 billion revenue in 2021, which is expected to reach USD 28.15 billion by 2030, growing at a cumulative rate of 15.6% over the forecast period. Parkinson’s Disease Treatment Market Report Highlights The global Parkinson’s disease treatment market size was valued at USD 4.28 billion in 2021, and it is expected to reach USD 11.98 billion by 2030, according to a new report by Grand View Research, Inc., growing at a CAGR of 12.7% from 2022 to 2030. By drug class, the Carbidopa-Levodopa segment held the largest revenue share in 2021 due to the high prevalence of PD and easy drug availability for the disease treatment The retail pharmacy distribution channel segment dominated the global industry in 2021 This is due to the easy availability of PD drugs in we...